J1921
HCPCSInj labetalol hcl hikma, 5mg
Official HCPCS Level II long descriptor
Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
HCPCS Level II code J1921 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj labetalol hcl hikma, 5mg
Added to HCPCS: 2023-07-01
Nearby codes in J1
- J1830Interferon beta-1b / .25 mg
- J1833Injection, isavuconazonium
- J1834Inj, isoniazid, 1 mg
- J1835Itraconazole injection
- J1836Inj, metronidazole, 10 mg
- J1837Inj, posaconazole, 1 mg
- J1885Ketorolac tromethamine inj
- J1920Inj, labetalol hcl, 5mg
- J1930Lanreotide injection
- J1931Laronidase injection
- J1932Inj, lanreotide, (cipla) 1mg
- J1938Inj, furosemide, 1 mg
- J1939Inj, bumetanide, 0.5 mg
- J1941Inj, furoscix, 20 mg
- J1943Inj., aristada initio, 1 mg
- J1944Aripiprazole lauroxil 1 mg
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.